SBFM Sunshine Biopharma, Inc.

-

Sunshine Biopharma Reported Earnings

Thursday, August 13, 2026 · 12:00 AM ET

Sunshine Biopharma (SBFM) reported a loss of $1.15 per share on revenue of $9.26 million for the second quarter ended June 2026. . Revenue fell 1.55% compared to the same quarter a year ago.

Sunshine Biopharma Inc. is a pharmaceutical company. It focused on the research, development and commercialization of oncology and antiviral drugs. Sunshine Biopharma Inc. is based in MONTREAL.

Earnings Whisper Grade
Power Rating
Reported Earnings
($1.15)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth-194.9 %
Reported Revenue
$9.26M
Revenue Estimate
Revenue Surprise
Revenue Growth-1.6 %